BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25

• Press Releases

  AdvanCell Appoints Sean Cassidy as Chief Financial Officer

  September 15, 2026

   · 

  3 min read
• Press Releases

  Microstructure Imaging Receives FDA Clearance for MICSI-PET, Bringing MR-Guided Enhancement and Automated Quantification to Neurological PET

  September 15, 2026

   · 

  1 min read
• Press Releases

  Coya Therapeutics Announces Enrollment of 100th Participant in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS

  September 15, 2026

   · 

  6 min read
• Press Releases

  Imvax Announces Additional Data from Phase 2b Clinical Trial of IGV-001 in Newly Diagnosed GBM and Provides Update on Planned Clinical Development

  September 15, 2026

   · 

  5 min read
• 

  Deals

  GSK bags Chimagen’s trispecific T cell engager in deal worth up to $750M

  After inking a T cell engager pact with Chimagen Biosciences a few years ago, GSK is back for more, this time acquiring a multiple myeloma program from the antibody specialist.

  September 15, 2026

   · 

  2 min read

   · 

  Gabrielle Masson
• 

  Layoffs

  GSK lays off 650 staffers amid closure of German vaccine manufacturing site

  GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid the pharma’s recent $2.5 billion savings campaign.

  September 15, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  MitoRx Therapeutics Appoints Clinical & Scientific Advisory Board to Guide the Development of MTRX31

  September 15, 2026

   · 

  7 min read
• Press Releases

  Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy

  September 15, 2026

   · 

  5 min read
• Press Releases

  Ernexa Therapeutics Reports Positive Disease Modifying ERNA-201 Preclinical Data, Reinforcing iMSC Platform as Company Accelerates Oncology Strategy and ERNA-101 Toward First-in-Human Dosing

  September 15, 2026

   · 

  13 min read
• Press Releases

  PolyPid Announces Participation in Upcoming Fall Investor Conferences

  September 15, 2026

   · 

  2 min read